| Critical role of TRPC6 channels in the formation of excitatory synapses J Zhou, W Du, K Zhou, Y Tai, H Yao, Y Jia, Y Ding, Y Wang Nature neuroscience 11 (7), 741-743, 2008 | 232 | 2008 |
| TRPC6 channels promote dendritic growth via the CaMKIV-CREB pathway Y Tai, S Feng, R Ge, W Du, X Zhang, Z He, Y Wang Journal of cell science 121 (14), 2301-2307, 2008 | 190 | 2008 |
| Inhibition of TRPC6 degradation suppresses ischemic brain damage in rats W Du, J Huang, H Yao, K Zhou, B Duan, Y Wang The Journal of clinical investigation 120 (10), 3480-3492, 2010 | 140 | 2010 |
| Stem cell-released oncolytic herpes simplex virus has therapeutic efficacy in brain metastatic melanomas W Du, I Seah, O Bougazzoul, G Choi, K Meeth, MW Bosenberg, ... Proceedings of the National Academy of Sciences 114 (30), E6157-E6165, 2017 | 116 | 2017 |
| Parkinson’s disease-risk protein TMEM175 is a proton-activated proton channel in lysosomes M Hu, P Li, C Wang, X Feng, Q Geng, W Chen, M Marthi, W Zhang, C Gao, ... Cell 185 (13), 2292-2308. e20, 2022 | 106 | 2022 |
| Functional roles of TRPC channels in the developing brain Y Tai, S Feng, W Du, Y Wang Pflügers Archiv-European Journal of Physiology 458, 283-289, 2009 | 77 | 2009 |
| TRPC 6 inhibited NMDA receptor activities and protected neurons from ischemic excitotoxicity H Li, J Huang, W Du, C Jia, H Yao, Y Wang Journal of neurochemistry 123 (6), 1010-1018, 2012 | 61 | 2012 |
| Lysosomal Zn2+ release triggers rapid, mitochondria-mediated, non-apoptotic cell death in metastatic melanoma W Du, M Gu, M Hu, P Pinchi, W Chen, M Ryan, T Nold, A Bannaga, H Xu Cell reports 37 (3), 2021 | 57 | 2021 |
| CRISPR-enhanced engineering of therapy-sensitive cancer cells for self-targeting of primary and metastatic tumors C Reinshagen, D Bhere, SH Choi, S Hutten, I Nesterenko, H Wakimoto, ... Science translational medicine 10 (449), eaao3240, 2018 | 49 | 2018 |
| Targeting breast to brain metastatic tumours with death receptor ligand expressing therapeutic stem cells T Bagci-Onder, W Du, JL Figueiredo, J Martinez-Quintanilla, K Shah Brain 138 (6), 1710-1721, 2015 | 45 | 2015 |
| TRP channels MX Zhu CRC Press, 2011 | 29 | 2011 |
| Targeting c-Met receptor overcomes TRAIL-resistance in brain tumors W Du, L Uslar, S Sevala, K Shah PLoS One 9 (4), e95490, 2014 | 28 | 2014 |
| Anti-EGFR VHH-armed death receptor ligand–engineered allogeneic stem cells have therapeutic efficacy in diverse brain metastatic breast cancers Y Kitamura, N Kanaya, S Moleirinho, W Du, C Reinshagen, N Attia, ... Science Advances 7 (10), eabe8671, 2021 | 14 | 2021 |
| TRPC channels in neuronal survival J Huang, W Du, H Yao, Y Wang | 12 | 2012 |
| Next-generation immunotherapies for brain metastatic cancers ML Vázquez, W Du, N Kanaya, Y Kitamura, K Shah Trends in cancer 7 (9), 809-822, 2021 | 6 | 2021 |
| A protocol to measure lysosomal Zn2+ release through a genetically encoded Zn2+ indicator M Gu, M Hu, T Minckley, P Pinchi, H Xu, Y Qin, W Du STAR protocols 3 (2), 101453, 2022 | 1 | 2022 |
| Anti-EGFR VHH-armed death receptor ligand-engineered stem cells have therapeutic efficacy in basal-like breast cancer brain metastasis Y Kitamura, N Kanaya, S Moleirinho, W Du, C Reinshagen, H Sasaki, ... Brain Tumor Research and Treatment 10 (Suppl), 2022 | | 2022 |
| OTHR-02. Engineered “of the shelf” allogeneic cellular therapies for metastatic brain tumors K Shah, Y Kitamura, W Du, N Kanaya Neuro-oncology Advances 3 (Suppl 3), iii14, 2021 | | 2021 |
| STEM-02. DEVELOPING BRAIN METASTATIC TUMOR MODELS FOR TARGETED STEM CELL THERAPY Y Kitamura, S Moleirinho, W Du, C Reinshagen, N Attia, K Shah Neuro-Oncology 20 (Suppl 6), vi243, 2018 | | 2018 |
| SCDT-26. STEM CELL LOADED ONCOLYTIC VIRUSES TRACK AND KILL METASTATIC BRAIN TUMORS K Shah, W Du, D Fisher Neuro-Oncology 19 (Suppl 6), vi270, 2017 | | 2017 |
